ID   L5178Y/hFASL
AC   CVCL_E4AB
SY   hFasL/L5178Y
RX   PubMed=7500022;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11936; FASLG.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C134997; Mouse thymic lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2097 ! L-5178-Y
SX   Female
AG   8M
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
RX   PubMed=7500022; DOI=10.1084/jem.182.6.1777; PMCID=PMC2192231;
RA   Kayagaki N., Kawasaki A., Ebata T., Ohmoto H., Ikeda S., Inoue S.,
RA   Yoshino K., Okumura K., Yagita H.;
RT   "Metalloproteinase-mediated release of human Fas ligand.";
RL   J. Exp. Med. 182:1777-1783(1995).
//